Five-year experience of corneal scrapes at Wellington Eye Department, New Zealand

New Zealand Medical Journal

Volumn 120, Issue 1260, 2007, Pages

  Rajpal, Kunaal ^a   Hall, Reece ^b   Long, Helen ^b   Wells, Anthony ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b Te Whatu Ora Health New Zealand Capital Coast Hutt Valley   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFALOTIN; CHLORAMPHENICOL; NEOMYCIN; PENICILLIN G;

ACCURACY; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS CEREUS; BACTERIAL EYE INFECTION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTACT LENS; CORNEA SURGERY; CORNEAL BIOPSY; CORYNEBACTERIUM; EYE DISEASE; FACTUAL DATABASE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GRAM STAINING; HUMAN; INFECTION RISK; KERATITIS; MEDICAL DOCUMENTATION; MORAXELLA; NEW ZEALAND; NONHUMAN; PEPTOSTREPTOCOCCUS; PROPIONIBACTERIUM; RETROSPECTIVE STUDY; RISK FACTOR; SERRATIA LIQUEFACIENS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS WARNERI; STREPTOCOCCUS PNEUMONIAE; CORNEA DISEASE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BACTERIOLOGICAL TECHNIQUES; CONTACT LENSES; CORNEAL DISEASES; EYE INFECTIONS, BACTERIAL; HUMANS; KERATITIS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEW ZEALAND; RETROSPECTIVE STUDIES;

EID: 34548434652     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Mcleod SD, Labree LD, Tayyanipour R, et al. The importance of initial management in the treatment of severe infectious corneal ulcers. Ophthalmology 1995; 102:1943-8.
2. Bourcier T, Thomas F, Borderie V, et al. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Opthalmol. 2003; 87:834-8.
3. Hall RC, McKellar MJ. Bacterial keratitis in Christchurch, New Zealand, 1997-2001. Clinical and Experimental Ophthalmology. 2004;32:478-81.
4. Kunimoto DY, Sharma S, Garg P, Rao GN. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Ophthalmology. 1999; 106:80-5
5. Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis: A 5-year review. Ophthalmology. 1999;106:1313-18
6. Tuft SJ, Matheson M. In vitro antibiotic resistance in bacterial keratitis in London. Br J Opthalmol. 2000;84:687-91.
7. Knauff HP, Silvany HP, Silvany R, et al. Susceptibility of corneal and conjunctival pathogens to ciprofloxacin. Cornea. 1996;15:66-71.
8. Morgan PB, Effron N, Hill EA, et al. Incidence of keratitis of varying severity among contact lens wearers. Br J Opthalmol. 2005;89:430-6.
9. Schein OD, Glynn RJ, Poggio EC, et al. The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. A case control study. N Engl J Med. 1989;321:773-8.
10. Keay L, Edwards K, Naduvilath T, et al. Microbial Keratitis predisposing factors and morbidity. Ophthalmology. 2006; 113:109-116.
11. Laspina F, Samudio M, Cibils D, et al. Epidemiological characteristics of microbiological results on patients with infectious corneal ulcers: A 13-year survey in Paraguay. Clinical & Experimental Ophthalmology. 2004;242:204-9.
12. Doona M, Walsh JB. Use of Chloramphenicol as topical eye medication: time to cry halt? BMJ. 1995;310:1217-18.